RASSF5 and lip and oral cavity carcinoma: Moreover, miR-214 regulated KB cell apoptosis through targeted inhibition of RASSF5 expression, FOXO3a phosphorylation, and BIM expression, suggesting its plausible application as a novel therapeutic oral cancer target [128].